Treatments for Congenital factor XIII deficiency

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

ℹ

Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.

Report missing data

FDA-approved treatments (2)

Corifact
factor XIII concentrate (human)
CSL Behring LLC
TRETTEN
coagulation factor XIII A-subunit (recombinant)
Novo Nordisk, Inc.

Patient support programs (2)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

TRETTEN

Novo Nordisk, Inc.

TRETTEN Patient Support (NovoCare)

Patient Assistance

Manufacturer Program

Accepting applications

Apply

Corifact

CSL Behring LLC

Corifact — Contact CSL Behring LLC

Unverified — confirm before calling

Patient Assistance

Manufacturer Program

Accepting applications

More about Congenital factor XIII deficiency

Disease overview →
Specialists →
Clinical trials →